Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Oshkosh
OSK
$9.7B
| $82.5M | 0.04% |
953,327
+333,072
| +54% | +$26.2M |
|
452
PUT
Delta Air Lines
DAL
$54.2B
| $82.2M | 0.04% |
1,730,100
-290,100
| -14% | -$10.7M |
|
453
HealthEquity
HQY
$8.81B
| $81.9M | 0.04% |
1,296,843
+127,935
| +11% | +$7.42M |
|
454
Eversource Energy
ES
$26.4B
| $81.4M | 0.04% |
1,147,796
+338,240
| +42% | +$25.2M |
|
455
PUT
Sun Life Financial
SLF
$44B
| $81.1M | 0.04% |
1,175,000
+100,000
| +9% | +$4.91M |
|
456
Roblox
RBLX
$27.4B
| $81.1M | 0.04% |
2,012,986
+1,855,948
| +1,182% | +$74.5M |
|
457
JPMorgan Chase
JPM
$935B
| $81.1M | 0.04% |
557,421
+179,566
| +48% | +$24.7M |
|
458
Textron
TXT
$14.3B
| $80.9M | 0.04% |
1,196,104
+281,736
| +31% | +$18.6M |
|
|
SUM
459
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $80.5M | 0.04% |
2,126,015
-134,181
| -6% | -$4.15M |
|
460
argenx
ARGX
$65B
| $80.2M | 0.04% |
205,893
+23,521
| +13% | +$9.25M |
|
461
PUT
Booking.com
BKNG
$158B
| $80.2M | 0.04% |
742,500
+300,000
| +68% | +$31.7M |
|
462
Neurocrine Biosciences
NBIX
$15.5B
| $80.2M | 0.04% |
850,258
+281,983
| +50% | +$27.6M |
|
463
monday.com
MNDY
$3.84B
| $79.8M | 0.04% |
465,912
+19,062
| +4% | +$2.85M |
|
464
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $79.2M | 0.04% |
1,054,500
-1,561,400
| -60% | -$117M |
|
465
PUT
Royal Bank of Canada
RY
$285B
| $79.1M | 0.04% |
625,000
| – | – |
|
466
Tenaris
TS
$26.6B
| $79M | 0.04% |
2,639,352
+967,899
| +58% | +$26.9M |
|
467
Cinemark Holdings
CNK
$4.24B
| $78.9M | 0.04% |
4,783,783
+75,645
| +2% | +$1.26M |
|
|
468
Salesforce
CRM
$171B
| $78.9M | 0.04% |
373,582
-1,221,081
| -77% | -$249M |
|
469
Tetra Tech
TTEK
$9.47B
| $78.8M | 0.04% |
2,407,735
+980,720
| +69% | +$28.8M |
|
|
FISV
470
Fiserv Inc
FISV
$28B
| $78.5M | 0.04% |
622,479
+242,049
| +64% | +$28.5M |
|
471
ConocoPhillips
COP
$162B
| $78.5M | 0.04% |
757,681
-660,810
| -47% | -$67.9M |
|
472
MSCI
MSCI
$41B
| $78.5M | 0.04% |
167,179
+63,275
| +61% | +$30.9M |
|
473
Saia
SAIA
$9.66B
| $78.4M | 0.04% |
228,834
+109,679
| +92% | +$31.7M |
|
|
HZNP
474
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $78.3M | 0.04% |
761,600
+706,100
| +1,272% | +$74.5M |
|
475
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $78.3M | 0.04% |
1,917,200
-600,200
| -24% | -$24.6M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.